Skip to main content

News

By Jeff Lagasse | 04:16 pm | April 12, 2022
Hackensack maintained the merger was in the best interest of patients, but is deferring to the appellate court's decision.
By Jeff Lagasse | 12:49 pm | April 12, 2022
HHS will weigh this information in its grantmaking decisions and share potential violations with the relevant enforcement agencies.
By Susan Morse | 11:37 am | April 12, 2022
The agency says it intends to issue proposed rules on minimum staffing level requirements within one year.
By Jeff Lagasse | 04:58 pm | April 11, 2022
The new round of investment is expected to result in the building of nearly 1,000 homes in Georgia, North Carolina and Oregon.
By Jeff Lagasse | 12:46 pm | April 11, 2022
The progress is slow and there are still problem areas, such as discharges, patient days and length of stay.
By Susan Morse | 11:40 am | April 11, 2022
The current public health emergency ends on April 16, but HHS has promised providers 60 days notice.
By Jeff Lagasse | 04:42 pm | April 08, 2022
Most of the deals were smaller transactions, a stark contrast to previous quarters involving mega mergers of higher dollar amounts.
By Jeff Lagasse | 12:24 pm | April 08, 2022
Protection against infection only lasts about a month, but protection against severe reaction to the virus lasts far longer.
By Susan Morse | 11:17 am | April 08, 2022
The American Society for Radiation Oncology has long expressed concerns about the model's reimbursement structure.
By Jeff Lagasse | 05:11 pm | April 07, 2022
Both Eliquis and Xarelto carry a price of more than $200 for a month's supply, a far cry from the $10 price tag for warfarin.